An NADPH-dependent reductase, first shown in the 1930s to catalyze the methylene blue-dependent reduction of methemoglobin in erythrocytes, has now been characterized as a high-affinity heme-binding protein and has been detected in liver. Highly purified bovine erythrocyte reductase binds protohemin to form a 1:1 complex with a Kd of 7 nM. Binding of protohemin completely inhibits reductase activity. Other tetrapyrroles and fatty acids also bind to the reductase and inhibit its activity. Protoporphyrin, hematoporphyrin, and coproporphyrin form 1:1 complexes withKd values ranging from 1 to 5 IzM. The inhibition constants for a number of saturated and unsaturated fatty acids range from 6 to 52 ,LM. A protein that is immunologically cross-reactive to the reductase has been detected in the cytosolic fractions of bovine and rat liver and of bovine, rat, rabbit, and human erythrocytes. By immunoblot analysis, the bovine liver and erythrocyte proteins appear identical in size, as do the rat liver and erythrocyte proteins. The concentration of the protein in bovine erythrocytes has been estimated by quantitative immunoblotting to be 10 juM. The detection of this protein in liver cells, the demonstration of its binding properties, and its weak reductase activity bring into question the long-held belief that this is uniquely an erythrocyte protein and that it functions as a reductase.
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Methylene blue stimulation of methemoglobin reduction in human erythrocytes was described 60 years ago by Warburg et al. (1) , Steele and Spink (2) , and Williams and Challis (3) . Subsequent work by a number of investigators resulted in preparations of a cytosolic NADPH-dependent reductase that catalyzed the reduction of methylene blue and flavins and, in the presence of redox couplers, catalyzed the reduction of methemoglobin (4) (5) (6) (7) (8) (9) . Whereas this NADPHdependent reductase is believed to contribute very little to methemoglobin reduction under normal conditions (10) , its catalysis of methemoglobin reduction in the presence of methylene blue or riboflavin is the basis for the use of these compounds as therapeutic agents in the treatment of congenital and toxic methemoglobinemia (11) (12) (13) . The erythrocyte reductase has variously been referred to as NADPH dehydrogenase, diaphorase, methemoglobin reductase, and, most recently, flavin reductase.
The reductase has been shown to bind small molecules. Isolation procedures generally yield two forms of the reductase, which exhibit very similar activities but different isoelectric points; one, but not the other, of these forms is reported to possess protein-bound NADP+ and a proteinbound yellow chromophore of unknown structure (7, 8, (14) (15) (16) . The isolation of the protein in the presence of flavin yields a flavoprotein (17) . The protein isolated without the addition of flavin contains no flavin and yet exhibits full reductase activity.
Recently (18), we obtained evidence that NADPHdependent reductase from bovine erythrocytes is structurally and immunochemically identical to the protein component of a green heme-binding protein that also has been isolated from bovine erythrocytes (19) . The green heme form of the protein is remarkable in that it undergoes rapid autoxidation and rapid reaction with peroxides (20) . This detection of NADPH-dependent reductase as a green heme-binding protein, together with the previous evidence that the protein binds NADP', flavin, and a yellow chromophore, has led us to further investigate the binding properties of this protein. In this paper, we report the characterization of highly purified bovine erythrocyte NADPH-dependent reductase as a binding protein with affinity for hemes, porphyrins, and fatty acids. We also report that this protein is present in liver as well as in erythrocytes. Some of these data have been presented in abstract form (21, 22 Bovine erythrocyte green heme-binding protein was purified as described (19) . Antibodies to the green heme-binding protein were raised in young adult male New Zealand White rabbits as described (18) . Bovine erythrocyte glutathione S-transferase was purified according to the method published for purification of this protein from horse erythrocytes (23) .
General Methods. Potassium phosphate buffers were used in all procedures unless otherwise indicated. Protein was quantitated by the Pierce BCA method using bovine serum albumin as standard. SDS/PAGE using 15% gels and isoelectric focusing under denaturing and nondenaturing conditions were performed by standard procedures (24, 25) . After electrotransfer to nitrocellulose, immunoblotting was carried out with antiserum to bovine erythrocyte green heme-binding protein, alkaline phosphatase-conjugated anti-rabbit IgG, 5-bromo-4-chloro-3-indolyl phosphate, and nitroblue tetrazolium (26, 27) . For quantitative immunoblots, nitrocellulose sheets were scanned with a soft-laser scanning densitometer (Helena Laboratories) with the purified bovine erythrocyte protein used as a standard.
NADPH-dependent reductase activities were assayed photometrically with methylene blue (1.3 tiM), 2,6-dichlorophenolindophenol (22 ,uM) , FMN (20 .uM) , and FAD (20 uM) as electron acceptors. Initial reaction rates were determined at 230C in 10 mM buffer (pH 7.5) under anaerobic conditions (17) . In addition, NADPH-dependent methylene blue reduc- Glutathione S-transferase activity was measured spectrophotometrically (23) . The protohemin complex of bovine erythrocyte glutathione S-transferase was prepared and was observed to have a Soret peak (absorbance maximum, 396 nm) that was less sharp and lower in extinction than the Soret peak (absorbance maximum, 396 nm) of protohemin (28) .
Preparation of Cytosolic Fractions for Immunochemical
Analyses. Cytosolic fractions were obtained from SpragueDawley rat, New Zealand White rabbit, bovine, and human erythrocytes. Washed, packed cells were lysed with 3 vol of cold water and the resulting hemolysates were frozen at -70°C. After thawing, membranes were sedimented by centrifuging at 13,000 x g for 60 min. The supernatant fractions were decanted and then stored at -70°C.
Cytosolic fractions were prepared from bovine and rat liver. Two-inch-thick slices of fresh bovine liver were immersed into ice-cold homogenization buffer (250 mM sucrose/1 mM EDTA/10 mM Tris acetate, pH 7.4) and were kneaded by hand to remove blood. Livers excised from Sprague-Dawley rats were briefly perfused by cannulating the portal vein and flushing the organ with homogenization buffer until the tissue turned from reddish-brown to light tan. The bovine and rat livers were disrupted with a Brinkman polytron model PT 10/35 and homogenized by a PotterElvehjem-type tissue grinder. Cytosolic fractions were obtained by centrifuging the homogenates at 100,000 X g for 70 min and the fractions were stored at -70°C. The amount of blood contaminating a liver sample was estimated by 'measuring absorbance at 416 and 280 nm in the liver homogenates and in an erythrocyte hemolysate. The upper limit of blood contamination in the liver sample was calculated assuming that all absorbance at 416 nm arises from oxyhemoglobin.
Purification of Bovine Erythrocyte NADPH-Dependent Reductase. Bovine erythrocyte reductase was obtained in highly purified form by truncation of the procedure used to purify the reductase from human erythrocytes (9) . Washed, packed erythrocytes were lysed with 3 vol of 1 mM 2-mercaptoethanol. The supernatant fraction derived from this hemolysate was applied to a DEAE-cellulose column using 2 mM buffer (pH 7.0) containing 0.1 mM dithiothreitol. The reductase was eluted with 0.1 M buffer (pH 7.0) containing 0.1 mM dithiothreitol. The reductase-containing fraction was concentrated by ultrafiltration on a YM-10 membrane and further purified on a Bio-Gel P-60 column using 50 mM buffer (pH 7.5) containing 0.1 mM dithiothreitol and 1 mM EDTA. The protein was further purified by repeating the gel-filtration step.
A yield of 87 mg of electrophoretically pure reductase was obtained from 6 liters of blood. This represents a 24% recovery based on the quantitation of reductase in erythrocytes by an immunoblotting technique. Isoelectric focusing revealed a single band (pl 6.8) under denaturing conditions and revealed one major band (pl 6.4) but several minor bands (pl 4.7-5.5) under nondenaturing conditions. The enzymatic and physical properties of the purified protein are similar to those reported for the NADPH-dependent reductase isolated from human and bullfrog erythrocytes (15) (16) (17) . The reductase catalyzes the transfer of electrons from NADPH to FMN, FAD, methylene blue, 2,6-dichlorophenolindophenol, and, through the mediation of flavin or methylene blue, to methemoglobin with turnover numbers (min'-) of 0.80, 0.50, 1.3, 2.0, 0.40, and 0.35, respectively. A molecular mass of 26 kDa was determined by both SDS/PAGE and gel-filtration chromatography on Bio-Gel P-100.
RESULTS
Protohemin-Binding Properties of NADPH-Dependent Methemoglobin Reductase. Addition of the reductase to protohemin solutions results in formation of a complex as demonstrated by changes of the protohemin spectrum (Fig. 1) . Analysis of the titration data yields a Kd for the reductaseprotohemin complex of 7 nM and a ratio of protohemin to reductase of 1:1.
Complex formation results in complete inhibition of reductase activity. No reductase activity, as assayed in the coupled methemoglobin reduction reaction, was observed in a 1 AM solution of reductase that had been incubated with a stoichiometric amount of protohemin. This is consistent with a Ki value comparable to the Kd value of 7 nM calculated for the reductase-protohemin complex.
The reductase-protohemin complex is reduced by sodium dithionite to a reductase-protoheme complex and, in the complexed state, both valence states undergo ligand exchange. The spectra of complexes of the reductase with protohemin, protohemin-cyanide, protoheme, and protoheme-CO (Fig. 2) show Soret bands with less absorbance and with maxima at longer wavelengths relative to the unbound heme compounds. The absorbance maxima of the complexed and unbound forms are found at 400 and 392 nm for protohemin, at 422 and 420 nm for protohemin-cyanide, at 420 and 414 nm for protoheme, and at 419 and 405 nm for protoheme-CO, respectively. The reductase-protohemin-cyanide minus , Reductase-protoheme complex prepared by addition of sodium dithionite; ---, reductase-protoheme-pyridine complex prepared by making the solution 1.6 M in pyridine and 0.1 M in sodium hydroxide and then adding sodium dithionite; --, reductase-protoheme-CO complex prepared by bubbling CO through the solution and then adding sodium dithionite.
reductase-protohemin difference spectrum shows absorbance maxima at 680, 546, 425, 357, and 245 nm, and absorbance minima at 615, 500, 383, 333, and 225 nm. Spectrophotometric titration with cyanide ion at 23°C yields a Kd of 1.6 MM for the dissociation of cyanide from the reductase-protohemin-cyanide complex. In contrast to these results, the spectrum ofthe protoheme-pyridine derivative is unchanged by the addition of reductase.
The reductase-protohemin complex shows a pI of6.5 upon isoelectric focusing under nondenaturing conditions. This is slightly higher than the value of 6.4 observed for the reductase in the absence of protohemin. The Dixon plot for the reductase-coproporphyrin complex (Fig. 3A) reveals a noncompetitive inhibition pattern and a K1 value of 1.4 ,uM.
Fatty acids also inhibit reductase activity as assayed in the coupled FMN-mediated methemoglobin reduction reaction (Fig. 3B) Immunodetection of the Heme-Binding Reductase in Erythrocytes. Using antiserum prepared to highly purified preparations of the bovine erythrocyte protein, an immunoreactive protein is observed in the cytosolic fraction of bovine, rat, rabbit, and human erythrocytes (Fig. 4) . Even though the same amount of total protein was loaded from each hemolysate, the intensity of the immunoreactive band was weaker for the rat, rabbit, and human proteins than for the bovine protein. polyacrylamide gel suggests a molecular mass of 26 kDa for the bovine and rabbit proteins, 27 kDa for the rat protein, and 25 kDa for the human protein.
Quantitative immunoblots performed on bovine hemolysate indicate that the protein is present at approximately a 10 ,uM concentration in bovine erythrocytes (immunoblots not shown).
Immnunodetection of the Heme-Binding Reductase in Liver. An immunoreactive protein is observed in the cytosolic fraction of bovine and rat liver (Fig. 5) . The immunoreactive band is more intense for the perfused rat livers than for the nonperfused livers, suggesting that the protein is derived from hepatic cells and not from contaminating erythrocytes. This suggestion was confirmed by hemoglobin analysis, which revealed that the upper limit for contamination of liver proteins by erythrocyte proteins was 2% for perfused rat liver, 5% for nonperfused rat liver, and 11% for bovine liver.
The bovine liver and erythrocyte immunoreactive proteins migrate identically, and the rat liver and erythrocyte proteins migrate identically. (19, 20) . The green heme associated with this protein has been shown to be a highly conjugated and polar hemin, markedly different from protohemin (29, 30) . The green protein is easily distinguished spectrally from the protohemin-reductase complex. It should be noted that in much earlier reports of the isolation of the reductase, the preparation exhibited a measurable hemeprotein spectrum (6, 8) . The reported hemeprotein spectrum might have resulted from hemoglobin contamination or from partial complexation of reductase and heme.
The reductase-protohemin complex has properties typical of hemeproteins. The complex is reduced by dithionite to generate a ferrous derivative that, like the ferric form, can undergo ligand exchange. We have shown that each of the complexes between reductase and four different derivatives of hemin is spectrally distinct from the corresponding free hemin derivatives (Fig. 2) . The pyridine hemochrome spectrum of the reductase-protoheme complex indicates that no chemical modification of hemin occurs upon complexation. The presence of the peak at 245 nm in the reductaseprotohemin-cyanide minus reductase-protohemin difference spectrum suggests that a histidyl residue serves as an axial ligand to iron in the ferric complex (31) . The location of the Soret band of the reductase-protoheme-CO complex at 419 nm indicates that in the ferrous form as well the protein provides to the iron a strong-field ligand, possibly a histidyl residue.
The reductase also binds microperoxidase and porphyrins to form 1:1 complexes that are inactive. Among the tetrapyrroles studied, greater affinity correlates with greater potency as an inhibitor. The affinity for these compounds is less than that for protohemin, probably as a result of steric The inhibition of reductase activity by saturated and unsaturated fatty acids, like inhibition by porphyrins, occurs at micromolar concentrations. Whereas no direct evidence for fatty acid binding was obtained, fatty acids were shown to compete with protohemin binding to the reductase (data not presented). It is reasonable to suggest that fatty acids, hemes, and porphyrins all interact with reductase at a hydrophobicbinding site that tolerates, or perhaps requires, anionic groups. The inhibition data demonstrate that none of these compounds is competitive with respect to FMN, and thus the binding site for these compounds is probably different than the FMN-binding site.
Immunoblotting techniques allowed quantitation of the reductase in bovine erythrocytes and detection of crossreactive proteins in erythrocytes of a number of species and in the cytosolic fraction of bovine and rat liver. The data indicate that the proteins from erythrocyte and liver have the same molecular mass. Among species, the molecular mass varies from 25 to 27 kDa.
By identifying the binding properties of the reductase, demonstrating that the protein is not unique to erythroid cells, determining that it is present at a relatively high intracellular concentration, and remembering that the reductase activity has a very low turnover number, we bring into question long-held beliefs as to the catalytic function of the protein. The protein may participate in transport, storage, or scavenging of heme, roles that have been suggested for intracellular heme-binding proteins (32) (33) (34) . Ongoing studies aim to establish whether the physiological significance of the protein relates to these heme-binding properties or, alternatively, whether the role of the protein is to (i) bind fatty acids, (ii) catalyze heme-regulated reduction reactions, or (iii) protect cells from oxidative damage by catalyzing the reduction of the higher oxidation states of hemeproteins.
